← Back to Search

Corticosteroid

Methylprednisolone Tablet for Finger sprain

Phase 2 & 3

Waitlist Available

Led By Brian Katt, MD

Research Sponsored by Robert Wood Johnson Barnabas Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up initial

Awards & highlights

No Placebo-Only Group

All Individual Drugs Already Approved

Approved for 50 Other Conditions

Summary

This trial is testing if steroids can help people with hand injuries that don't need surgery by reducing inflammation. The goal is to see if this treatment improves their ability to move and use their hands.

Eligible Conditions

Finger sprain
Hand Injuries
Finger Injuries

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

MCP, DIP, PIP of digits 2-5: Extension

MCP, DIP, PIP of digits 2-5: Flexion

MCP, DIP, PIP of digits 2-5: abduction

+11 more

Secondary study objectives

Complications

Edema Measurements

VAS Pain Scale

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

All Individual Drugs Already Approved

Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Approved for 50 Other Conditions

This treatment demonstrated efficacy for 50 other conditions.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Steroid GroupExperimental Treatment1 Intervention

Patients receive 21 tablets of 4 mg methylprednisolone to be taken by mouth over a 6 week taper. Patients will be advised to not take other anti-inflammatory medications like NSAIDs.

Group II: Control GroupActive Control1 Intervention

Patients will recieve standard treatment that focuses on mobilization and stabilization using common techniques like buddy taping and splinting. Pain control will be managed using non-NSAID medications like Tylenol or opioid narcotics when deemed medically necessary.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Methylprednisolone

FDA approved

Do I qualify?Apply below to find out